REV1 Antikörper
Kurzübersicht für REV1 Antikörper (ABIN7231002)
Target
Alle REV1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Rabbit Anti-REV1 Polyclonal Antibody
-
Spezifität
- The antibody detects endogenous levels of REV1 protein
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from part region of human REV1 protein
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- REV1 (REV1, Polymerase (DNA Directed) (REV1))
-
Andere Bezeichnung
- REV1
-
Hintergrund
- DNA repair protein REV1, Alpha integrin-binding protein 80, AIBP80, Rev1-like terminal deoxycytidyl transferaseREV1 encodes REV1, DNA Directed Polymerase with similarity to the S. cerevisiae mutagenesis protein Rev1. The Rev1 proteins contain a BRCT domain, which is important in protein-protein interactions. A suggested role for the human Rev1-like protein is as a scaffold that recruits DNA polymerases involved in translesion synthesis (TLS) of damaged DNA.
-
Molekulargewicht
- 137kD
-
Gen-ID
- 51455
-
UniProt
- Q9UBZ9
-
Pathways
- DNA Reparatur, Regulation of Actin Filament Polymerization, Production of Molecular Mediator of Immune Response
Target
-